| Jennifer Nolan, | |
|
64 Double Hill Rd, Bethlehem, CT 06715 | |
| (860) 262-3747 | |
| Not Available |
| Full Name | Jennifer Nolan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 64 Double Hill Rd, Bethlehem, Connecticut |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528502853 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 6673 (Connecticut) | Primary |
| Entity Name | Connecticut Renaissance, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700893807 PECOS PAC ID: 0941253728 Enrollment ID: O20050222000611 |
News Archive
Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
An international study led by Loyola University Chicago is providing compelling new evidence that exercise is not the key to controlling weight.
Mosquirix, the first malaria vaccine to be submitted for regulatory approval, has gained the support of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
A new Joint Doctoral Program (JDP) in Interdisciplinary Research on Substance Use has been launched by the Division of Global Public Health in the University of California, San Diego School of Medicine and San Diego State University's School of Social Work. The program will emphasize research devoted to studying the use and misuse of alcohol and drugs - and related social and health consequences.
› Verified 6 days ago
| Entity Name | Minding Your Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841763901 PECOS PAC ID: 3779825864 Enrollment ID: O20190418002468 |
News Archive
Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
An international study led by Loyola University Chicago is providing compelling new evidence that exercise is not the key to controlling weight.
Mosquirix, the first malaria vaccine to be submitted for regulatory approval, has gained the support of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
A new Joint Doctoral Program (JDP) in Interdisciplinary Research on Substance Use has been launched by the Division of Global Public Health in the University of California, San Diego School of Medicine and San Diego State University's School of Social Work. The program will emphasize research devoted to studying the use and misuse of alcohol and drugs - and related social and health consequences.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Nolan, 560 Michelle Ln, Thomaston, CT 06787-1289 Ph: (860) 262-3747 | Jennifer Nolan, 64 Double Hill Rd, Bethlehem, CT 06715 Ph: (860) 262-3747 |
News Archive
Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.
An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.
An international study led by Loyola University Chicago is providing compelling new evidence that exercise is not the key to controlling weight.
Mosquirix, the first malaria vaccine to be submitted for regulatory approval, has gained the support of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
A new Joint Doctoral Program (JDP) in Interdisciplinary Research on Substance Use has been launched by the Division of Global Public Health in the University of California, San Diego School of Medicine and San Diego State University's School of Social Work. The program will emphasize research devoted to studying the use and misuse of alcohol and drugs - and related social and health consequences.
› Verified 6 days ago
Tara Moseni, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 64 Double Hill Rd, Bethlehem, CT 06751 Phone: 203-884-8652 | |
Ms. Erin Rauscher, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 64 Double Hill Rd, Bethlehem, CT 06751 Phone: 203-884-8652 |